EB-101 Surgical application of RDEB wounds ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
36表皮水疱症1

36. 表皮水疱症


臨床試験数 : 163 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05725018
(ClinicalTrials.gov)
March 24, 202323/1/2023EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)A Phase 3b Study for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) in New and Previously EB-101 Treated PatientsEpidermolysis Bullosa;Recessive Dystrophic Epidermolysis Bullosa;RDEBBiological: EB-101 Surgical application of RDEB woundsAbeona Therapeutics, IncNULLNot yet recruiting6 YearsN/AAll12Phase 3United States